All stock lists
Mentari Therapeutics, Inc. (NASDAQ:MTRI)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$19.10+$0.75 (+4.09%)
Market cap
$10.5M
Insider Score
Health Score
Analyst consensus
Listed since
May 5, 2014
Website
Insider Score
49/ 100
MTRI Insider Score
Neutral16 qualifying trades · 1 insider · $238.37K bought in the last 90 days
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
MTRI Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New MTRI patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MTRI from public contracts
Source: USAspending.gov
Recently reported changes in MTRI holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing MTRI, reported under the STOCK Act.
| No congressional trades recorded for MTRI. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.